1. Introduction
===============

Steroids are a large class of organic compounds. They play a very important role in animals, plants and microorganisms. The best known steroid is certainly cholesterol. Cholesterol was isolated for the first time from gall stones nearly two centuries ago by Chevreul \[[@B1-molecules-19-04212],[@B2-molecules-19-04212]\]. This sterol is an important component of mammalian cell membranes; it is also present in significant concentrations in the brain and nervous tissue \[[@B3-molecules-19-04212],[@B4-molecules-19-04212],[@B5-molecules-19-04212],[@B6-molecules-19-04212]\]. Cholesterol is the biosynthetic precursor of steroid hormones, bile acids, vitamin D and lipoproteins \[[@B7-molecules-19-04212],[@B8-molecules-19-04212],[@B9-molecules-19-04212]\]. Like the functions of cholesterol in mammals, ergosterol is necessary to support the life of fungi. It serves two main purposes: a bulk membrane function and a sparking function. Ergosterol is a biological precursor to vitamin D~2~ (ergocalciferol) \[[@B10-molecules-19-04212],[@B11-molecules-19-04212],[@B12-molecules-19-04212]\].

All sterols are crystalline compounds with a secondary hydroxyl group in the position C(3) of the steroid skeleton, one or two double bonds and differently modified side chains. Rings A/B of the steroid skeleton may have *trans* geometry (the allo series) or *cis* (the normal series). Sterols have the hydroxy group on the C(3) position forming a number of β-sterols with respect to the average plane of the ring. By contrast bile acids have hydroxy groups on the C(3) position which prefer the α orientation \[[@B13-molecules-19-04212],[@B14-molecules-19-04212],[@B15-molecules-19-04212],[@B16-molecules-19-04212],[@B17-molecules-19-04212]\].

Bile acids are major metabolites of cholesterol, being end products of its metabolism in the liver \[[@B18-molecules-19-04212],[@B19-molecules-19-04212]\]. They are isolated from the bile of higher animals, where they are found as sodium salts of peptide conjugates with glycine and taurine. The most important are the primary bile acids, e.g., chenodeoxycholic acid and cholic acid, which are successively transformed into secondary bile acids such as ursodeoxycholic, deoxycholic and lithocholic acids \[[@B20-molecules-19-04212],[@B21-molecules-19-04212],[@B22-molecules-19-04212]\]. Bile acids (e.g., lithocholic, deoxycholic and cholic) are very interesting because they display a large, rigid, and curved skeleton. Moreover, they possess chemically different polar hydroxy groups (3α, 3α,7α and 3α,7α,12α) and amphiphilic properties. Modifications of the functional groups of sterol molecules allow one to obtain systems with high pharmacological activity \[[@B23-molecules-19-04212]\].

Quaternary alkylammonium salts play an important role in the living organisms and many functions of prokaryotic and eukaryotic cells have been shown to be alkylammonium salts dependent \[[@B24-molecules-19-04212],[@B25-molecules-19-04212]\]. These compounds also exhibit excellent antimicrobial activity, and therefore they are used as antiseptics, bactericides and fungicides, as well as therapeutic agents. In general, quaternary alkylammonium salts with good antimicrobial activities contain one or two alkyl chains with lengths in the C~8~--C~14~ range. For the applications as softeners and hair conditioning agents hydrocarbon chain lengths between C~16~ and C~18~ are used \[[@B26-molecules-19-04212],[@B27-molecules-19-04212],[@B28-molecules-19-04212]\]. Phthalimides, and *N*-substituted phthalimides are also an important class of compounds because of their biological activities as antimicrobial agents \[[@B29-molecules-19-04212],[@B30-molecules-19-04212]\]. It has recently been shown that tetrachlorophthalimide derivatives are good α-glucosidase inhibitors \[[@B31-molecules-19-04212]\]. The use of microbiocides of the same type for a long time may cause an increase of resistance of microorganisms to the chemicals used, which is a very serious and dangerous problem. Antimicrobial resistance of bacteria comprises a wide variety of biochemical mechanisms and processes that allow microorganisms to grow in the presence of microbiocides \[[@B32-molecules-19-04212],[@B33-molecules-19-04212],[@B34-molecules-19-04212]\]. There are many ways to overcome the risk of an increasing resistance of microorganisms, however the best one is a periodically application of new microbiocides with modified structures \[[@B35-molecules-19-04212],[@B36-molecules-19-04212]\]. Therefore, connections of sterols and bile acids with various amines or polyamines appears to be an unusually interesting potential approach to such new structures \[[@B37-molecules-19-04212],[@B38-molecules-19-04212],[@B39-molecules-19-04212],[@B40-molecules-19-04212]\].

2. Results and Discussion
=========================

In the present work, the synthesis and physicochemical properties of some new quaternary *N*,*N*-dimethyl-3-phthalimidopropylammonium conjugates of sterols (ergosteryl 3β-bromoacetate (**4**), cholesteryl 3β-bromoacetate (**5**), dihydrocholesteryl 3β-bromoacetate (**6**)) and derivatives of bile acids (methyl litocholate 3α-bromoacetate (**13**), methyl deoxycholate 3α-bromoacetate (**14**) and methyl cholate 3α-bromoacetate (**15**)) with *N*,*N*-dimethyl-3-phthalimidopropylamine in acetonitrile are investigated.

New quaternary 3-phthalimidopropylammonium conjugates of steroids were obtained by reaction of ergosterol (**1**), cholesterol (**2**), cholestanol (5α-cholestan-3β-ol, **3**), and bile acids **10**--**12** with bromoacetic acid bromide to give **4**--**6** and **13**--**15**. The 3β-bromoacetates of sterols and 3α-bromoacetates of bile acids, as well as *N*,*N*-dimethyl-3-phthalimidopropylamine were prepared according to the literature procedures \[[@B41-molecules-19-04212],[@B42-molecules-19-04212]\]. The structure of products was confirmed by ^1^H-NMR, ^13^C-NMR, and FT-IR analysis, as well as ESI-MS and MALDI. The syntheses of conjugates **7--9** and **16**--**18** are shown in [Scheme 1](#molecules-19-04212-f010){ref-type="scheme"}.

![Synthesis of quaternary phthalimidopropylammonium conjugates of sterols **7**--**9** (**a**) and bile acids **16**--**18** (**b**).](molecules-19-04212-g010){#molecules-19-04212-f010}

Potential pharmacological activities of the synthesized compounds have been determined on the basis of computer-aided drug discovery approach with *in silico* Prediction of Activity Spectra for Substances (PASSs) program. It is based on a robust analysis of the structure-activity relationship in a heterogeneous training set currently including about 60,000 biologically active compounds from different chemical series with about 4,500 types of biological activities. Since only the structural formula of the chemical compound is necessary to obtain a PASS prediction, this approach can be used at the earliest stages of investigation. There are many examples of the successful use of the PASS approach leading to new pharmacological agents \[[@B43-molecules-19-04212],[@B44-molecules-19-04212],[@B45-molecules-19-04212],[@B46-molecules-19-04212],[@B47-molecules-19-04212]\]. The PASS software is useful for the study of biological activity of secondary metabolites. We have selected the types of activities that were predicted for a potential compound with the highest probability (focal activities). If predicted activity is higher than 0.7 (PA \> 0.7), the substance is very likely to exhibit the activity in experiment and the chance of the substance being the analogue of a known pharmaceutical agent is also high. If predicted activity is between 0.5 and 0.7 (0.5 \< PA \< 0.7), the substance is unlikely to exhibit the activity in experiment and the similarity to known pharmaceutical substance is very limited.

The structures of all synthesized compounds were determined from their ^1^H- and ^13^C-NMR, FT-IR and ESI-MS spectra. Moreover, PM5 calculations and B3LYP *ab initio* methods were performed for all compounds. Additionally, analyses of the biological prediction activity spectra for the new esters prepared herein are good examples of *in silico* studies of chemical compounds. We also selected the types of activity that were predicted for a potential compound with the highest probability (focal activities) ([Table 1](#molecules-19-04212-t001){ref-type="table"}). According to these data the most frequently predicted types of biological activity are: inhibitors glyceryl-ether monooxygenase, acylcarnitine hydrolase, alkylacetylglycerophosphatase, plasmanylethanolamine desaturase, *N*-(acyl)ethanolamine deacylase and protein-disulfide reductase.

molecules-19-04212-t001_Table 1

###### 

"Probability to be Active" (PA) values for the predicted biological activity of **7**--**9** and **16**--**18**.

  Focal Predicted Activity (PA \> 0.80)              Compounds                               
  -------------------------------------------------- ----------- ------ ------ ------ ------ ------
  Glyceryl-ether mono-oxygenase inhibitor            0.87        0.91   0.93   0.93   0.94   0.95
  Acylcarnitine hydrolase inhibitor                  \-          \-     0.81   0.83   0.91   0.94
  Alkylacetylglycerophosphatase inhibitor            \-          \-     \-     0.82   0.90   0.86
  Plasmanylethanolamine desaturase inhibitor         \-          \-     \-     \-     0.71   0.78
  CYP3A4 substrate                                   \-          \-     \-     \-     0.70   0.73
  *N*-(acyl)ethanolamine-deacylase inhibitor         \-          \-     \-     \-     0.73   0.76
  Protein-disulfide reductase inhibitor              \-          \-     0.72   \-     0.75   \-
  Alkenylglycerophosphocholine hydrolase inhibitor   \-          \-     \-     \-     0.80   \-
  Oxidoreductase inhibitor                           0.87        0.77   \-     \-     \-     \-
  Alcohol *O*-acetyl-transferase inhibitor           0.88        \-     \-     \-     \-     \-
  DELTA14-sterol reductase inhibitor                 \-          0.73   \-     \-     \-     \-
  Alkylacetylglycerophosphatase inhibitor            \-          \-     0.84   \-     \-     \-
  Antieczematic                                      \-          \-     \-     0.72   \-     \-
  Glucan endo-1,3-β-D-glucosidase inhibitor          \-          \-     \-     \-     0.73   \-
  D-lactaldehyde dehydrogenase inhibitor             \-          \-     \-     \-     \-     0.74

The ^1^H-NMR spectra of compounds **7**--**9** show characteristic multiplets in the range 4.96--4.48 ppm assigned to the C3α--H protons of the sterol skeleton. Similarly, compounds **16**--**18** exhibit multiplets in the range 4.92--4.55 ppm which are assigned to the C3β--H protons of the bile acid skeleton ([Figure 1](#molecules-19-04212-f001){ref-type="fig"}). A proton singlet at 0.83 ppm for **7** and singlets in the range of 0.68--0.64 ppm for other conjugates are assigned to CH~3~--18. The other singlets ranging from 1.04--0.79 ppm, 0.91 ppm and 0.89 ppm are assigned to CH~3~--19 for **7**--**9**, **17** and **18**, respectively. In the case of compound **16** signal of the CH~3~--19 group and CH~3~--21 group form the multiplet. The characteristic doublets of CH~3~--21, with the exception of conjugate **16**, are observed at 0.98--0.90 ppm and are assigned to conjugates **7**--**10**, **17** and **18**.

![^1^H-NMR spectra in the region (8.0--3.5 ppm) of the most characteristic signals of conjugates **8** (**a**) and **18** (**b**).](molecules-19-04212-g001){#molecules-19-04212-f001}

The characteristic doublets of the ergosterol-substituted derivatives are observed at 1.01 ppm for CH~3~--28 group and 0.84 ppm for CH~3~--27 and CH~3~--26 groups, respectively. The ^1^H-NMR spectra of conjugates **8** and **9** show doublets at 0.87 and doublet of doublets at 0.86 ppm of the C(26) and C(27) methyl group. In the ^1^H-NMR spectra of sterol conjugates **7**--**9** and bile acid conjugates **16**--**18** a signal of protons of the COCH~2~N^+^ group in the range 5.35--4.55 ppm is observed. The peaks of six methyl protons of the N^+^(CH~3~)~2~ and two methylene protons of the N^+^CH~2~ appear as singlets and multiplets or broad singlets in the range 3.69--3.61 ppm and 4.96--3.87 ppm, respectively. Two methylene protons of attached to the phthalimide ring--N--CH~2~ group are seen as a broad singlets in the 3.83--3.82 ppm range.

The ^13^C-NMR spectra of conjugates **7**--**9** and **16**--**18** in CDCl~3~ show characteristic signals at 15.80 ppm (**7**), 12.66--11.79 ppm (**8**, **9**, **16**--**18**), and 19.19--17.25 ppm (**7**, **8**, **16**--**18**), 12.18 ppm (**9**) which are assigned to CH~3~--18 and CH~3~--19, respectively. Carbon atoms of the CH~3~--21 group for all conjugates give signals in the ranges 22.55--18.621 ppm. Characteristic shifts of methyl groups present in the sterol side chain (CH~3~--26 and CH~3~--27) are positioned in the range 22.76--19.94 ppm and 22.52--19.61 ppm, respectively. The carbon atoms of the CO~2~CH~3~ unit resonated in the range of 174.77--174.72 ppm and 52.49--51.45 ppm, assigned to CO~2~ and CH~3~, respectively.

Two important signals for C(1\')=O and C(3)--O lie at 164.25--163.87 ppm and 77.97--74.87 ppm, respectively. The spectra of all conjugates show two diagnostic signals associated with CH~2~ atoms in N^+^--C(2\')H~2~--CO and N^+^--C(4\')H~2~ groups. The carbon atoms of the first group are observed at 62.25--60.67 ppm and carbon atoms of the second group lie at 61.50--61.05 ppm for **8**, **9** and **16**--**18** and 57.03 ppm for **7**, respectively. The carbon atoms of N^+^(CH~3~)~2~ group appear in the range of 53.16--51.42 ppm. The carbon atoms of (C(7\')=O)~2~N--C(6\')H~2~ group resonate in the range of 168.34--168.09 ppm and 62.25--60.67 ppm assigned to C(7\')=O and C(6\')H~2~, respectively.

The proton chemical shift assignments of *N,N*-dimethyl-(3β-acetate-cholest-5-ene)-3-phthal-imidopropylammonium bromide (**8**) ([Table 2](#molecules-19-04212-t002){ref-type="table"}) are based on 2D COSY experiments, in which the proton-proton connectivity is observed through the off-diagonal peaks in the counter plot.

molecules-19-04212-t002_Table 2

###### 

Chemical shifts (δ, ppm) in D~2~O and calculating GIAO nuclear magnetic shielding tensors (σ~cal~) for *N,N*-dimethyl-(3β-acetate-cholest-5-ene)-3-phthalimido- propylammonium bromide **(8)**. The predicted GIAO chemical shifts were computed from the linear equation δ~exp~ = a + b σ~calc~ with a and b determined from the fit the experimental data.

            δ~exp.~   δ~calc~   σ~calc~             δ~exp.~   δ~calc~   σ~calc~
  --------- --------- --------- ---------- -------- --------- --------- ---------
  C1\'      163.90    160.96    98.55      H2\'     4.80      5.94      26.538
  C2\'      62.05     66.51     168.03     H3\'     3.66      3.58      28.992
  C3\'      52.38     44.94     183.90     H4\'     3.95      4.94      27.566
  C4\'      61.05     58.56     173.88     H5\'     \-        \-        30.748
  C5\'      23.76     20.94     201.56     H6\'     3.83      4.16      28.389
  C6\'      37.63     44.15     184.48     H9\'     7.83      7.08      25.346
  C7\'      168.12    154.39    105.71     H10\'    7.77      7.00      25.430
  C8\'      131.72    134.68    117.88     H3       3.66      3.58      28.987
  C9\'      123.49    128.37    122.52     H6       5.35      5.04      27.472
  C10\'     134.22    137.31    115.95     H18      0.68      0.80      32.113
  C3        76.57     78.28     159.37     H19      0.99      0.82      31.924
  C5        138.76    138.26    115.25     H21      0.92      0.58      32.112
  C6        123.33    127.64    123.06     H26,27   0.87      0.76      31.924
  C18       11.79     9.93      209.66     \-       \-        \-        \-
  C19       19.19     35.13     191.12     \-       \-        \-        \-
  C21       18.65     25.79     197.99     \-       \-        \-        \-
  C26       22.76     14.29     206.45     \-       \-        \-        \-
  C27       22.50     11.67     208.38     \-       \-        \-        \-
  a ^a^     \-        \-        294.9163   \-       \-        31.4274   \-
  b ^b^     \-        \-        -1.3593    \-       \-        -0.9606   \-
  r^2\ c^   \-        \-        0.9831     \-       \-        0.9443    \-

^a^ intercept; *^b^* slope; *^c^* correlation coefficient.

The relations between the experimental ^1^H- and ^13^C-NMR chemical shifts (δ~exp~) and the Gauge-Independent Atomic Orbitals (GIAO) isotropic magnetic shielding tensors (σ~calc~) for **8** are shown in [Figure 2](#molecules-19-04212-f002){ref-type="fig"}. Both correlations are linear, described by the equation: δ~exp.~ = a + bσ~calc~. The a and b parameters are given in [Table 2](#molecules-19-04212-t002){ref-type="table"}. The very good correlation coefficients (r^2^ = 0.9379) for ^1^H and (r^2^ = 0.9984) for ^13^C correlations of *N*,*N*-di-methyl-(3β-acetate-cholest-5-ene)-3-phthalimidopropyl-ammonium bromide confirm the optimized geometry of **8**.

![Experimental chemical shifts (δ~exp~.) for *N,N*-dimethyl-(3β-acetate-cholest-5-ene)-3-phthalimidopropylammonium bromide (**8**) *vs.* isotropic magnetic shielding constants (σ~calc~) from the GIAO/B3LYP/6-31G(d,p) calculations; (**a**) carbons-13 and (**b**) protons.](molecules-19-04212-g002){#molecules-19-04212-f002}

The correlation between the experimental chemical shifts and calculated isotropic screening constants are better for carbon atoms than for protons. The protons are located on the periphery of the molecule and thus they are exposed to stronger interactions with solvent than carbon atoms, which are more hidden inside of structure. The differences between the exact values of the calculated and experimental shifts for protons are probably due to the fact that the shifts are calculated for single molecules in gas phase, whereas experimental values are due to the condensed phase. For this reason the agreement between the experimental and the calculated data for protons are worse than for carbons.

PM5 semiempirical calculations were performed using the WinMopac 2003 program and B3LYP calculation are performed using the GAUSSIAN 03 program package with the 6-31G(d,p) basis set. The final heat of formation (HOF) and energies for the sterols **1**--**3**, bile acids **10**--**12** as well as their conjugates **7**--**9** and **16**--**18** is presented in [Table 3](#molecules-19-04212-t003){ref-type="table"}. Representative conjugates of sterol **7** and bile acid **18** are shown in [Figure 3](#molecules-19-04212-f003){ref-type="fig"}.

molecules-19-04212-t003_Table 3

###### 

Heat of formation (HOF) \[kcal/mol\] and energy \[a.u.\] of sterols (**1**--**3**), bile acids (**10**--**12**) and their conjugates (**7**--**9**, **16**--**18**).

  Compound   Heat of Formation   ΔHOF       Energy         ΔEnergy
  ---------- ------------------- ---------- -------------- --------------
  1          -97.1208            \-         -1113.175477   \-
  2          -140.1058           \-         -1118.205536   \-
  3          -162.7945           \-         -1119.450757   \-
  7          -177.1668           -80.0460   -4569.562486   -3456.387009
  8          -220.6382           -80.5324   -4570.807880   -3452.602344
  9          -243.3231           -80.5286   -4605.917678   -3486.466921
  10         -236.1585           \-         -1204.997432   \-
  11         -278.4616           \-         -1263.040016   \-
  12         -318.1685           \-         -1337.190617   \-
  16         -306.6215           -70.4630   -4640.248926   -3435.251494
  17         -348.9986           -70.5370   −4714.391510   -3451.351494
  18         -388.2588           −70.0903   -4788.548913   -3451.358296

ΔHOF = HOF~conjugates\ (**7**--**9**)~ -- HOF~sterols\ (**1**--**3**);~ΔHOF = HOF~conjugates\ (**16-18**)~ -- HOF~bile\ acids\ (**10**--**12**)~; ΔEnergy = Energy~conjugates\ (**7**--**9**)~ -- Energy~sterols\ (**1**--**3**);~ΔEnergy = Energy~conjugates\ (**16**--**18**)~ -- Energy~bile\ acids\ (**10**--**12**)~.

![Molecular models of representative compounds **7** and **18** calculated by the PM5 method.](molecules-19-04212-g003){#molecules-19-04212-f003}

The lowest values of HOF for sterols are observed for cholestanol **3** and its conjugate **9**, where there are no double bonds which stabilize the molecule and hinder its reactivity, in contrast to conjugates of ergosterol **7** and cholesterol **8** where the double bonds increase the reactivity of the molecule, thereby increasing values of HOF. The HOF relationship for methyl esters of bile acids **10**--**12** and their corresponding conjugates **16**--**18** can be explained in a similar manner. In this case, the number of hydroxyl groups in the steroid skeleton lowers the value of the determinant of HOF. This spatial arrangement of bile acids can facilitate the formation of stable host-guest complexes. These complexes may be stabilized by hydrogen bonding or electrostatic interactions that arise from the number of hydroxyl groups in the bile acid molecule. Similar correlations have been observed using the B3LYP method.

The spatial arrangement and interaction of the conjugates **7** and **18** are shown in [Figure 4](#molecules-19-04212-f004){ref-type="fig"}. The final heat of formation is --1249.429 kcal/mol for **7** and --1358.893 kcal/mol for **18** and the distances between the quaternary nitrogen and the anion bromide are 4.34 Å and 4.33 Å, respectively. Compensation charges occurs only through intermolecular electrostatic interaction. This is a very good confirmation of the conclusion that interactions reduce HOF. The dipole moments and selected geometry parameters were calculated at the PM5 and B3LYP /6-31G(d,p) level of theory are presented in [Table 4](#molecules-19-04212-t004){ref-type="table"}.

![Molecular models of conjugates **7** and **18** calculated by the PM5 method.](molecules-19-04212-g004){#molecules-19-04212-f004}

molecules-19-04212-t004_Table 4

###### 

Calculated structural parameters (B3LYP\\6-31G(d,p), **PM5**) for sterol conjugates **7**--**9** as well as bile acid conjugates **16**--**18**.

  Parameters                                  7        8        9        16       17       18
  ------------------------------------------- -------- -------- -------- -------- -------- --------
  Dipole moments (Debye)                      9.0817   8.9725   8.8533   8.9578   8.4897   7.7646
  Bond lengths \[Å\]                                                                       
  N(1)-C(7\')                                 1.451    1.451    1.451    1.459    1.459    1.459
  1.428                                       1.427    1.428    1.431    1.432    1.430    
  N(1)-C(3\')                                 1.495    1.494    1.494    1.492    1.492    1.451
  1.471                                       1.471    1.471    1.469    1.469    1.469    
  C(1\')-O(3)                                 1.261    1.260    1.260    1.262    1.263    1.262
  1.219                                       1.220    1.219    1.220    1.220    1.220    
  N(2)-C(4\')                                 1.573    1.570    1.573    1.572    1.572    1.571
  1.546                                       1.546    1.546    1.543    1.544    1.543    
  N(2)-C(2\')                                 1.570    1.574    1.570    1.571    1.572    1.571
  1.527                                       1.527    1.527    1.525    1.525    1.525    
  C(7\')-O(1)                                 1.260    1.261    1.260    1.255    1.255    1.255
  1.210                                       1.210    1.210    1.208    1.208    1.208    
  Bond angles \[°\]                                                                        
  C(6\')-C(5\')-C(4\')                        111.5    112.0    112.2    108.8    109.1    108.8
  110.8                                       110.7    110.9    108.0    108.1    107.7    
  N(1)-C(6\')-C(5\')                          112.2    112.1    112.1    111.5    111.3    111.5
  110.4                                       110.5    110.4    110.4    110.5    110.8    
  C(4\')-N(2)-C(2\')                          105.3    105.4    105.5    105.6    105.8    105.6
  105.6                                       105.5    111.5    105.6    105.6    105.4    
  N(2)-C(2\')-C(1\')                          111.6    111.6    111.5    111.3    111.1    111.4
  114.2                                       114.0    114.0    113.9    113.9    114.0    
  C(2\')-C(1\')-O(3)                          106.7    106.8    106.9    107.6    102.1    107.6
  109.2                                       109.4    109.4    109.6    109.1    109.5    
  Torsion angles \[°\]                                                                     
  C(7\')-N(1)-C(6\')-C(5\')                   −58.1    −60.0    −60.8    58.3     57.3     58.5
  −82.2                                       −80.3    −79.4    86.8     85.5     77.6     
  C(8\')-C(7\')-N(1)-C(6\')                   −177.9   −178.5   −178.8   178.2    178.9    178.1
  179.9                                       −176.9   −178.0   −177.8   −178.1   178.1    
  C(5\')-C(4\')-N(2)-C(2\')                   170.0    171.4    172.1    178.3    178.0    178.2
  172.9                                       172.1    172.4    −169.2   −168.5   −170.6   
  C(3\')-N(2)-C(2\')-C(1\')                   53.6     56.3     56.1     56.3     56.4     56.5
  61.7                                        53.1     52.7     55.6     56.2     55.1     
  C(6\')-C(5\')-C(4\')-N(2)                   −99.3    −98.4    −98.0    −179.8   179.1    179.8
  −104.8                                      −103.8   −103.2   −167.7   −167.3   −172.0   
  Hydrogen bonds and short contacts lengths                                                
  Distances \[Å\]                                                                          
  C(4\')-H···Br                               3.149    3.147    3.147    3.157    3.159    3.159
  3.283                                       3.288    3.288    3.434    3.291    3.303    
  C(2\')-H···Br                               3.077    3.076    3.075    3.067    3.064    3.068
  3.075                                       3.080    3.075    3.051    3.045    3.303    
  N(2)···Br                                   3.370    3.372    3.373    3.369    3.368    3.370
  3.459                                       3.464    3.463    3.458    3.463    3.459    
  Angles \[deg\]                                                                           
  C(4\')-H···Br                               153.0    153.6    153.9    153.5    153.3    153.4
  144.1                                       143.8    143.9    139.1    138.2    139.4    
  C(2\')-H···Br                               157.7    158.0    158.0    158.4    158.5    158.4
  149.6                                       150.5    150.1    152.0    153.1    152.5    

The calculated bond lengths and bond angles for **7**--**9** and **16**--**18** optimized by the PM5 and B3LYP methods are quite similar, however the bond lengths N(2)-C(2\') and N(2)-C(4\') are different. Also the torsion angles calculated by the PM5 and B3LYP methods are slightly different, especially the C(5\')-C(4\')-N(2)-C(2\') angle for fatty acid conjugates **16**--**18**. This shows a crucial role of electrostatic interaction between oppositely charged groups in the structure of the investigated compounds ([Table 4](#molecules-19-04212-t004){ref-type="table"}). Hydrogen bonds and short contact lengths distances are shorter for compounds calculated by B3LYP method. These data prove that in the gas phase the type of quantum chemical methods used play an important role in the molecular structure of ionic compounds. The solid-state IR spectra of sterols and bile acids conjugates are shown in [Figure 5](#molecules-19-04212-f005){ref-type="fig"} and [Figure 6](#molecules-19-04212-f006){ref-type="fig"}, respectively.

![FT-IR spectra of sterol conjugates **7** (red) and **8** (blue) in the 3,100--400 cm^−1^ region.](molecules-19-04212-g005){#molecules-19-04212-f005}

![FT-IR spectra of bile acid conjugates **16** (blue), **17** (red), **18** (black) in the 3100--400 cm^−1^ region](molecules-19-04212-g006){#molecules-19-04212-f006}

The FT-IR spectra of conjugates show characteristic bands at 1,775--1,772 cm^−1^ which are due to the asymmetric carbonyl group ν~as~C=O stretching vibrations in a phthalimide moiety ([Figure 5](#molecules-19-04212-f005){ref-type="fig"}, [Figure 6](#molecules-19-04212-f006){ref-type="fig"}, [Figure 7](#molecules-19-04212-f007){ref-type="fig"} and [Figure 8](#molecules-19-04212-f008){ref-type="fig"}) \[[@B48-molecules-19-04212],[@B49-molecules-19-04212]\]. The symmetric ν~s~C=O stretching vibration appears in the FT-IR spectrum as an intense and broad nonsymmetrical band at 1,716--1,699 cm^−1^ suggesting the small nonequivalence of carbonyl groups in the phthalimide moiety. Moreover strong characteristic bands in the region 1,251--1,240 cm^−1^ are present, which are assigned to the *ν*(C--O).

![FT-IR spectra of bile acid conjugates in the carbonyl group region **16** (blue), **17** (red), **18** (black).](molecules-19-04212-g007){#molecules-19-04212-f007}

![Spectrum of *N,N*-dimethyl-(3β-acetate-5β-cholestan)-3-phthalimidopropyl-ammonium bromide (**9**); (**a**) FT-IR (**b**) calculated scaled FT-IR spectrum.](molecules-19-04212-g008){#molecules-19-04212-f008}

The FT-IR spectra of bile acid conjugates ([Figure 7](#molecules-19-04212-f007){ref-type="fig"}, blue line) shows characteristic vibration bands of ν~as~C=O and ν~s~C=O in a phthalimide moiety at 1,773 cm^−1^ and at 1,712 and 1,699 cm^−1^, respectively. In this case the ν~as~C=O and ν~s~C=O bands are more nonsymmetrical in comparison to the carbonyl bands of **17** and **18**. The nonequivalence of ν~as~C=O in the FT-IR spectrum is observed for *N,N*-bis-(phthalimidopropyl)-*N*-propylamine \[[@B50-molecules-19-04212]\]. In contrast to the above examples, in *N,N*-dimethyl-3-phthalimidopropylammonium hydrochloride monohydrate and *N*-*n*-butyltetrachlorophthalimide no split of the carbonyl bands in FT-IR spectra were observed, in spite of the different interactions of each carbonyl group in the supramolecular structure \[[@B51-molecules-19-04212],[@B52-molecules-19-04212]\]. The ν(COO) stretching vibrations of carboxy groups are observed at 1,747--1,736 cm^−1^ ([Figure 7](#molecules-19-04212-f007){ref-type="fig"}).

The room-temperature solid-state FT-IR and the calculated spectrum of **9** are shown in [Figure 8](#molecules-19-04212-f008){ref-type="fig"}. The band frequencies, relative intensities and their assignments in the 4,000--400 cm^−1^ range are listed in [Table 5](#molecules-19-04212-t005){ref-type="table"}. For convenience of comparison, the band intensities for the calculated spectrum are scaled.

molecules-19-04212-t005_Table 5

###### 

Observed and calculated B3LYP/6-31G(d,p) vibrational frequencies and infrared intensities for *N,N*-dimethyl-(3β-acetate-5β-cholestan)-3-phthalimidopropylammonium bromide (**9**).

  IR        IR~calc.~   IR~calc~.~scaled~   INT    Proposed Assignment   
  --------- ----------- ------------------- ------ --------------------- --
  3,462w    3,477       3,344               3.34   nCH                   
  3,459w    3,467       3,333               17.8   nCH                   
  3,380w    3,464       3,330               5.26   nCH                   
  3,304w    3,419       3,286               18.2   nCH~2~                
  3,243w    3,391       3,259               381    nCH~2~                
  3,060w    3,252       3,125               10.9   nCH~2~                
  3,048s    3,225       3,098               6.74   nCH~2~                
  2,952s    3,189       3,063               8.81   nCH~3~                
  2,933s    3,167       3,042               16.7   nCH~3~                
  2,930s    3,111       2,988               485    nCH~2~                
  2,867s    2,988       2,869               515    nCH~2~                
  2,851s    2,966       2,847               994    nCH~2~                
  2,719w    \-          \-                  \-     nCH∙∙∙Br              
  2,649w    2,531       2,486               1982   nCH∙∙∙Br              
  2,534w    \-          \-                  \-     nCH∙∙∙Br              
  1,770m    1,845       1,761               16.9   n~as~CO               
  1,742s    1,811       1,728               55.6   nCOO                  
  1,712s    1,800       1,718               190    n~s~CO                
  1,635vw   1,728       1,650               2.38   nCC                   
  1,614w    1,706       1,627               2.13   nCC                   
  \-        1,679       1,600               4.59   nCC                   
  \-        1,671       1,593               29.7   nCC                   
  \-        1,636       1,558               17.7   nCC                   
  1,467s    1,608       1,532               14.2   nCC                   
  1,454m    1,581       1,505               2.76   nCC, βCH~2~           
  1,445 m   1,577       1,502               14.1   β~as~CH~3~            
  1,437m    1,529       1,455               17.2   βCH~2~                
  1,396s    1,432       1,361               175    βOH                   
  1,375 m   1,430       1,359               15.7   β~s~CH~3~             
  1,364 m   1,424       1,353               178    nCO                   
  1,335 w   1,406       1,336               3.82   nCC                   
  1,313 w   1,379       1,310               18.5   nCN                   
  1,285 w   1,361       1,292               10.4   nCC                   
  1,272 w   1,343       1,275               34.6   nCC, βCH~2~           
  1,251 m   1,331       1,263               82.7   nCO                   
  1228 m    1,290       1,224               17.7   βCH~2~                
  1,209 s   1,268       1,202               232    nCC                   
  1,188 m   1,251       1,186               10.8   nCC                   
  1,176 m   1,236       1,172               4.70   nCC                   
  1,150 w   1,225       1,161               11.5   nCN                   
  1,142 w   1,217       1,153               135    nCN                   
  1,132 w   1,214       1,150               141    βCH                   
  1,108 w   1,202       1,138               25.0   nCN                   
  1,089 w   1,192       1,128               169    nCN                   
  1,074 w   1,179       \-                  10.6   γCH~2~                
  1,044 w   1,141       1,116               14.3   γCH~2~                
  1,037 w   1,124       1,079               3.42   γCH~2~                
  1,026 w   1,106       1,063               3.28   δCH~2~                
  1,017 m   1,098       1,045               5.41   βCH~2~                
  1,001 m   1,074       1,037               32.5   γCH~2~                
  978 w     1,047       1,014               13.0   βCCC                  
  964 w     1,025       988                 3.87   βCO                   
  950 w     1,016       967                 13.6   γCH~2~                
  935 w     998         958                 3.96   βCH~2~                
  927 w     966         941                 43.5   γCH~2~                
  904 w     963         909                 25.0   γCH~2~                
  897 w     920         907                 6.08   βCCC                  
  887 w     901         907                 2.12   βCCC                  
  860 vw    895         865                 2.04   tring                 
  842 vw    879         847                 5.89   nCC                   
  802 vw    867         825                 3.62   βCCC                  
  787 vw    813         814                 13.5   βCCC                  
  720 m     764         761                 11.0   βCCC                  
  710 vw    751         714                 1.86   βCNC                  
  692 vw    746         701                 8.70   βring                 
  663 vw    698         694                 3.00   γCH                   
  636 vw    659         612                 0.13   γCH                   
  625 vw    657         610                 28.5   γCH                   
  605 vw    650         603                 3.71   βring                 
  600 vw    625         579                 6.76   βNCC                  
  545 vw    610         565                 15.1   γCC                   
  531 w     566         522                 7.31   βCCC                  
  512 vw    551         508                 14.9   tring                 
  498 vw    540         497                 12.4   tring                 
  482 vw    515         472                 10.3   γCCC                  
  438 vw    469         428                 1.23   Lattice mode          
  419 vw    434         394                 11.4   Lattice mode          
  409 vw    409         370                 9.39   Lattice mode          
  \-        386         348                 5.04   Lattice mode          
  \-        345         308                 22.0   Lattice mode          
  \-        329         292                 57.4   Lattice mode          
  \-        282         247                 3.62   Lattice mode          
  \-        257         223                 10.3   Lattice mode          
  \-        205         172                 5.27   Lattice mode          
  \-        177         145                 1.08   Lattice mode          
  \-        102         72                  1.63   Lattice mode          
  \-        56          28                  2.59   Lattice mode          

The abbreviations are: s: strong; m: medium; w: weak; vw; very weak; ν: stretching; β: in plane bending; δ: deformation; w: wagging; γ: out of plane bending and τ: twisting.

The DFT harmonic vibrational wavenumbers are usually higher than the experimental values. However, in this case the overall agreement between the experimental and calculated frequencies for (**9**) is very good ([Figure 9](#molecules-19-04212-f009){ref-type="fig"}).

![Correlation between the experimental and calculated wavenumbers (cm^−1^) for (**9**); ν~scaled~ = -26.3525 + 0.9689ν~calc.~, r^2^ = 0.9973.](molecules-19-04212-g009){#molecules-19-04212-f009}

Any discrepancy noted between the observed and calculated frequency may be due to the fact that the calculations have been done for a single molecule in the gaseous state contrary to the experimental spectrum recorded in the presence of intermolecular interactions. The scaling procedure, as recommended by Palafox was used \[[@B53-molecules-19-04212],[@B54-molecules-19-04212]\]. The scaled IR spectrum is shown in [Figure 8](#molecules-19-04212-f008){ref-type="fig"}b and the predicted frequencies are listed in [Table 3](#molecules-19-04212-t003){ref-type="table"} as ν~scaleq~. Scaling of the harmonic vibrational frequencies reproduce the experimental solid-state FT-IR frequencies with the r.m.s. error of 38.1 cm^−1^. The vibrational band assignments of 9 were made using Gauss-View molecular visualization program \[[@B55-molecules-19-04212]\].

3. Experimental
===============

3.1. General
------------

The NMR spectra were measured with a Varian Mercury 300 MHz NMR spectrometer (Oxford, UK), operating at 300.07 and 75.4614 for ^1^H and ^13^C, respectively. Typical conditions for the proton spectra were: pulse width 32°, acquisition time 5 s, FT size 32 K and digital resolution 0.3 Hz per point, and for the carbon spectra pulse width 60°, FT size 60 K and digital resolution 0.6 Hz per point, the number of scans varied from 1200 to 10,000 per spectrum. The ^13^C and ^1^H chemical shifts were measured in CDCl~3~ relative to an internal standard of TMS. Infrared spectra were recorded in the KBr pellets using a FT-IR Bruker IFS 66 spectrometer (Karlsruhe, Germany). The ESI (electron spray ionization) mass spectra were recorded on a Waters/Micromass (Manchester, UK) ZQ mass spectrometer equipped with a Harvard Apparatus (Saint Laurent, QC, Canada), syringe pump. The sample solutions were prepared in methanol at the concentration of approximately 10^−5^ M. The standard ESI-MS mass spectra were recorded at the cone voltage 110 V. The MALDI (matrix-assisted laser desorption/ionization) mass spectra were recorded on a Waters Maldi Q-Tof Premiere. The sample solutions were prepared in methanol at the concentration of approximately 10^−5^ M. The matrix was 2,5-dihydroxybenzoic acid (gentisic acid) and the standard was β-cyclodextrin (*m/z* 1157.3218). PM5 semiempirical calculations were performed using the WinMopac 2003 program \[[@B56-molecules-19-04212],[@B57-molecules-19-04212],[@B58-molecules-19-04212]\]. The calculations were performed using the GAUSSIAN 03 program package \[[@B59-molecules-19-04212]\] at the B3LYP \[[@B60-molecules-19-04212],[@B61-molecules-19-04212],[@B62-molecules-19-04212]\] levels of theory with the 6-31G(d,p) basis set \[[@B63-molecules-19-04212]\]. The NMR isotropic shielding constants were calculated using the standard Gauge-Independent Atomic Orbital (GIAO) approach of Gaussian 03 \[[@B64-molecules-19-04212],[@B65-molecules-19-04212]\].

3.2. Synthesis
--------------

The appropriate 3β-bromoacetate of sterols or 3α-bromoacetate of bile acids (0.20 mmol) were dissolved in CH~3~CN (6 mL) under reflux. Then *N*,*N*-dimethyl-3-phthalimidopropylamine (0.24 mmol) was added and the mixture heated under reflux for 3 h. The precipitate was filtered and crystallized from CH~3~CN-EtOH (90:1), to give white solids.

*N,N-Dimethyl-(3β-acetate-ergosta-5,7,22-triene)-3-phthalimidopropylammonium bromide* (**7**): white solid (76%), m.p. 185--187 °C. ^1^H-NMR: δ~H~ 7.85 (bs, 2H, Ar--H), 7.75 (bs, 2H, Ar--H), 5.35 (s, 2H, COCH~2~N^+^), 5.31--5.12 (m, 4H, 6, 7, 22, 23--H), 4.96--4.58 (m, 3H, 3α--H, N^+^CH~2~), 3.82 (bs, 2H, CH~2~--N--phthalimide ring), 3.69 (s, 6H, N^+^(CH~3~)~2~), 1.04 (s, 3H, CH~3~--19), 1.01 (d, *J* = 6,0 Hz, 3H, CH~3~--28), 0.93 (d, *J* = 6.7 Hz, 3H, CH~3~--21), 0.84 (d, *J* = 6.7 Hz, 6H, CH~3~--26 and CH~3~--27), 0.83 (s, 3H, CH~3~--18). ^13^C-NMR: δ~C~ 168.17 (C-7\'), 163.98 (C-1\'), 140.11 (C-8), 139.96 (C-5), 135.43 (C-22), 134.32, 132.08 (C-23), 131.81, 123.57, 118.11 (C-6), 118.03 (C-7), 74.87 (C-3), 62.40, 61.67, 60.67 (C-2\'), 57.03 (C-4\'), 53.16 (C-3\'), 44.76, 42.79, 40.80, 40.72, 38.86, 36.82, 36.65, 36.44, 36.40, 34.93, 34.03, 33.81, 33.05, 27.58, 27.45, 26.43, 25.10, 25.04, 22.81, 21.77 (C-21), 20.96 (C-19), 19.94, 19.61, 18.28, 18.20, 17.63, 15.80 (C-18). FT-IR (KBr) ν~max~: 2957, 2871, 1773, 1740, 1713, 1466, 1437, 1396, 1365,1250, 1208, 1044, 926. ESI-MS (*m/z*): 670 (100%) \[C~43~H~61~N~2~O~4~\]^+^. MALDI-MS (*m/z*): 669.9. HRMS: calcd 669.5678 for C~43~H~61~N~2~O~4~; found 669.5630.

*N,N-Dimethyl-(3β-acetate-cholest-5-ene)-3-phthalimidopropylammonium bromide* (**8**): white solid (82%), m.p. 199--200 °C. ^1^H-NMR: δ~H~ 7.85--7.80 (m, 2H, Ar--H), 7.76--7.70 (m, 2H, Ar--H), 5.35 (d, *J* = 4.9 Hz, 1H, 6--H), 4.80 (bs, 2H, COCH~2~N^+^), 4.69--4.48 (m, 1H, 3α--H), 4.00--3.89 (m, 2H, N^+^CH~2~), 3.83 (bs, 2H, CH~2~--N--phthalimide ring), 3.66 (s, 6H, N^+^(CH~3~)~2~), 0.99 (s, 3H, CH~3~--19), 0.92 (d, *J* = 6.4 Hz, 3H, CH~3~--21), 0.87 (dd, *J* = 6.6, 1.4 Hz, 6H, CH~3~--26 and CH~3~--27), 0.68 (s, 1H, CH~3~--18). ^13^C-NMR: δ~C~168.12 (C-7\'), 163.90 (C-1\'), 138.76 (C-5), 134.22, 131.72, 123.49, 123.33 (C-6), 76.57 (C-3), 62.05 (C-2\'), 61.05 (C-4\'), 56.60, 56.06, 52.38 (C-3\'), 49.93, 42.24, 39.62, 39.44, 37.63, 36.75, 36.44, 36.11, 35.71, 34.63, 31.84, 31.72, 29.64, 28.15, 27.95, 27.42, 24.21, 23.76, 22.76, 22.50, 20.95, 19.19 (C-19), 18.65 (C-21), 11.79 (C-18). FT-IR (KBr) ν~max~: 2943, 2868, 1774, 1737, 1713, 1467, 1637, 1395, 1364, 1252, 1210, 1089, 925. ESI-MS (*m/z*): 660 (100%) \[C~42~H~63~N~2~O~4~\]^+^. MALDI-MS (*m/z*): 659.9. HRMS: calcd 659.5812 for C~42~H~63~N~2~O~4~; found 659.5802.

*N,N-Dimethyl-(3β-acetate-5β-cholestan)-3-phthalimidopropylammonium bromide* (**9**): white solid (83%), m.p. 191--192 °C. ^1^H-NMR: δ~H~ 7.83 (d, *J* = 3.90 Hz, 2H, Ar--H), 7.74 (m, 2H, Ar--H), 4.88--4.55 (m, 3H, COCH~2~N^+^, 3α--H), 3.92 (bs, 2H, N^+^CH~2~), 3.83 (bs, 2H, CH~2~--N--phthalimide ring), 3.61 (s, 6H, N^+^(CH~3~)~2~), 0.90 (d, *J* = 6.5 Hz, 3H, CH~3~-21), 0.86 (dd, *J* = 6.7, 1.9 Hz, 6H, CH~3~--26 and CH~3~--27), 0.79 (s, 3H, CH~3~--19), 0.65 (s, 1H, CH~3~--18). ^13^C-NMR: δ~C~ 168.18 (C-7\'), 163.89 (C-1\'), 134.26, 131.74, 123.51, 76.68 (C-3), 62.25 (C-2\'), 61.27 (C-4\'), 56.34, 56.21, 54.10, 52.51 (C-3\'), 44.62, 42.52, 39.90, 39.45, 36.56, 36.11, 35.74, 35.34, 34.65, 33.55, 31.90, 29.65, 28.44, 28.18, 27.96, 27.13, 24.14, 23.79, 22.78, 22.56, 22.52, 21.15, 18.62 (C-21), 12.18 (C-19), 12.02 (C-18). FT-IR (KBr) ν~max~: 2952, 2867, 1770, 1742, 1712, 1467, 1445, 1396, 1375, 1251, 1089, 927. ESI-MS (*m/z*): 661 (100%) \[C~42~H~65~N~2~O~4~\]^+^. MALDI-MS (*m/z*): 661.5. HRMS: calcd 661.5905 for C~42~H~65~N~2~O~4~; found 661.5917.

*N,N-Dimethyl-(methyl litocholate)-3-phthalimidopropylammonium bromide* (**16**): white solid (96%), m.p. 104--105 °C. ^1^H-NMR: δ~H~ 7.86--7.82 (m, 2H, Ar--H), 7.77--7.73 (m, 2H, Ar--H), 4.84--4.67 (m, 3H, 3β--H, COCH~2~N^+^), 3.92 (bs, 2H, N^+^CH~2~), 3.83 (bs, 2H, CH~2~--N--phthalimide ring), 3.66 (s, 9H, CO~2~CH~3~ and N^+^(CH~3~)~2~), 0.91 (m, 6H, CH~3~--19 and CH~3~--21), 0.64 (s, 3H, CH~3~--18). ^13^C-NMR: δ~C~ 174.72 (C-24), 168.09 (C-7\'), 163.87 (C-1\'), 134.24, 131.73, 123.45, 77.97 (C-3), 62.11 (C-2\'), 61.14 (C-4\'), 56.15, 55.79, 52.49 (C-3\'), 51.42 (C-25), 43.04, 42.64, 41.89, 40.23, 39.89, 35.68, 35.28, 35.02, 34.81, 34.61, 34.45, 31.76, 31.00, 30.93, 28.10, 26.84, 26.23, 26.13, 24.09, 23.16, 22.53, 20.76 (C-21), 18.21 (C-19), 11.97 (C-18). FT-IR (KBr) ν~max~: 2937, 2867, 1773, 1746, 1737, 1712, 1698, 1466, 1438, 1404, 1378, 1210, 1088, 930. ESI-MS (*m/z*): 664 (100%) \[C~40~H~59~N~2~O~6~\]^+^. MALDI-MS (*m/z*): 663.5. HRMS: calcd 663.5361 for C~40~H~59~N~2~O~6~; found 663.5396.

*N,N-Dimethyl-(methyl deoxycholate)-3-phthalimidopropylammonium bromide* (**17**): white solid (90%), m.p. 170--172 °C. ^1^H-NMR: δ~H~ 7.87--7.83 (m, 2H, Ar--H), 7.76--7.72 (m, 2H, Ar--H), 4.92--4.67 (m, 3H, 3β--H, COCH~2~N^+^), 3.98 (s, 1H, 12β--H), 3.96--3.87 (m, 2H, CH~2~--N^+^), 3.82 (bs, 2H, CH~2~--N--phthalimide ring), 3.63 (s, 9H, CO~2~CH~3~ and N^+^(CH~3~)~2~), 0.98 (d, *J* = 5.7 Hz, 3H, CH~3~--21), 0.91 (s, 3H, CH~3~--19), 0.66 (s, 3H, CH~3~--18). ^13^C-NMR: δ~C~ 174.75 (C-24), 168.30 (C-7\'), 164.00 (C-1\'), 134.26, 131.76, 123.55, 77.66 (C-3), 72.81 (C-12), 62.07 (C-2\'), 61.39 (C-4\'), 52.55 (C-3\'), 51.45 (C-25), 48.04, 47.08, 46.40, 41.81, 35.86, 35.13, 34.71, 34.03, 33.37, 31.62, 31.07, 30.90, 28.61, 27.41, 26.77, 26.09, 25.97, 23.62, 22.87, 22.55 (C-21), 17.26 (C-19), 12.66 (C-18). FT-IR (KBr) ν~max~: 2955, 2870, 1774, 1736, 1716, 1485, 1466, 1405, 1393, 1201, 1091, 967. ESI-MS (*m/z*): 680 (100%) \[C~40~H~59~N~2~O~7~\]^+^. MALDI-MS (*m/z*): 679.5. HRMS: calcd 679.5358 for C~40~H~59~N~2~O~7~; found 679.5341.

*N,N-Dimethyl-(methyl cholate)-3-phthalimidopropylammonium bromide* (**18**): white solid (85%), m.p. 204--205 °C. ^1^H-NMR: δ~H~ 7.86--7.83 (m, 2H, Ar--H), 7.76--7.69 (m, 2H, Ar--H), 4.95 (s, 2H, COCH~2~N^+^), 4.66--4.55 (m, 1H, 3β--H), 3.97 (bs, 1H, 12β--H), 3.92--3.89 (m, 2H, CH~2~--N^+^), 3.82 (bs, 2H, CH~2~--N--phthalimide ring), 3.80 (bs, 1H, 7β--H), 3.63 (s, 3H, CO~2~CH~3~,), 3.62 (s, 6H, N^+^(CH~3~)~2~), 0.97 (d, *J* = 5.8 Hz, 3H, CH~3~--21), 0.89 (s, 3H, CH~3~--19), 0.66 (s, 3H, CH~3~--18). ^13^C-NMR: δ~C~ 174.77 (C-24), 168.34 (C-7\'), 164.25 (C-1\'), 134.19, 131.78, 123.49, 76.57 (C-3), 72.62 (C-12), 67.75 (C-7), 61.86 (C-2\'), 61.50 (C-4\'), 52.50 (C-3\'), 51.41 (C-25), 46.95, 46.35, 41.89, 41.22, 39.54, 35.26, 34.86, 34.66, 34.37, 31.13, 30.91, 28.37, 27.45, 26.68, 26.30, 23.13, 22.55, 22.32 (C-21), 17.25 (C-19), 12.47 (C-18). FT-IR (KBr) ν~max~: 2938, 2870, 1772, 1739, 1711, 1468, 1437, 1399, 1370, 1208, 1073, 953. ESI-MS (*m/z*): 696 (100%) \[C~40~H~59~N~2~O~8~\]^+^. MALDI-MS (*m/z*): 695.5. HRMS: calcd 695.5192 for C~40~H~59~N~2~O~8~; found 695.5242.

4. Conclusions
==============

In conclusion, six new quaternary *N*,*N*-dimethyl-3-phthalimidopropylammonium conjugates of sterols (compounds **7**--**9**) and bile acids (compounds **16**--**18**) were prepared by the reactions of ergosteryl 3β-bromoacetate, cholesteryl 3β-bromoacetate, dihydrocholesteryl 3β-bromoacetate as well as methyl litocholate 3α-bromoacetate, methyl deoxycholate 3α-bromoacetate and methyl cholate 3α-bromoacetate, with *N*,*N*-dimethyl-3-phthalimidopropylamine in acetonitrile. These new compounds were characterized by spectroscopic and molecular structure methods. The obtained conjugates may find applications in molecular recognition and in pharmacology, especially as compounds with a high antimicrobial activity.
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